Michael J Boyer (M Boyer, Michael Boyer)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 14

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

International journal of molecular sciences

BMC cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

Chris O’Brien Lifehouse

University of Sydney (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Chris O’Brien Lifehouse

Australia

Senior Staff Specialist :: Medical Oncology

Education History

University of Sydney

Australia

BSC

Publications

A Khoo, Michael J Boyer, Zuhayr Jafri, T Makeham, T Pham, Levon Michael Khachigian, Peter Floros, E Dowling, K Fedder, David C Shonka, J Garneau, C H O'Meara
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives. International journal of molecular sciences 25 (5) (2024)
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael J Boyer, Kai He, Neeltje Steeghs, Hiroki Izumi, Melissa Lynne Johnson, Tatsuya Yoshida, Hasna Bouchaab, Hossein Borghaei, Enriqueta Felip Font, Philipp J Jost, Shirish M Gadgeel, Xi Chen, Youfei Yu, Pablo Martinez, Amanda Parkes, Luis G Paz-Ares
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
A Khoo, Michael J Boyer, Zuhayr Jafri, T Makeham, T Pham, Levon Michael Khachigian, Peter Floros, E Dowling, K Fedder, David C Shonka, J Garneau, C H O'Meara
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives. International journal of molecular sciences 25 (5) (2024)
Michael J Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study. BMC cancer 23 (Suppl 1) (2024)
A Khoo, Michael J Boyer, Zuhayr Jafri, T Makeham, T Pham, Levon Michael Khachigian, Peter Floros, E Dowling, K Fedder, David C Shonka, J Garneau, C H O'Meara
Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives. International journal of molecular sciences 25 (5) (2024)
Michael J Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study. BMC cancer 23 (Suppl 1) (2024)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Connor H O'Meara, Thanh Vinh Nguyen, Zuhayr Jafri, Michael J Boyer, David C Shonka, Levon Michael Khachigian
Personalised Medicine and the Potential Role of Electrospinning for Targeted Immunotherapeutics in Head and Neck Cancer. Nanomaterials (Basel, Switzerland) 14 (1) (2023)
Jhanelle E Gray, Myung-Ju Ahn, Geoffrey R Oxnard, Frances A Shepherd, Fumio Imamura, Ying Cheng, Isamu Okamoto, Byoung Chul Cho, Meng-Chih Lin, Yi-Long Wu, Margarita Majem Tarruella, Oliver Gautschi, Michael J Boyer, Krishna C Bulusu, Aleksandra A Markovets, J Carl Barrett, Rachel Hodge, Astrid McKeown, Ryan J Hartmaier, Juliann Chmielecki, Vassiliki A Papadimitrakopoulou, Suresh R Ramalingam
Early Clearance of Plasma Epidermal Growth Factor Receptor Mutations as a Predictor of Outcome on Osimertinib in Advanced Non-Small Cell Lung Cancer; Exploratory Analysis from AURA3 and FLAURA. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Connor H O'Meara, Thanh Vinh Nguyen, Zuhayr Jafri, Michael J Boyer, David C Shonka, Levon Michael Khachigian
Personalised Medicine and the Potential Role of Electrospinning for Targeted Immunotherapeutics in Head and Neck Cancer. Nanomaterials (Basel, Switzerland) 14 (1) (2023)
Jonathon Lo, Kieran Ballurkar, Simonie Fox, Kate Tynan, Nghiep Luu, Michael J Boyer, Raghav Murali-Ganesh
A Digital Coaching Intervention for Cancer Survivors With Job Loss: Retrospective Study. JMIR cancer 7 (4) (2021)
Michael J Boyer, Mehmet A N Şendur, Delvys Rodriguez Abreu, Keunchil Park, Dae Ho Lee, Irfan Cicin, Perran Fulden Yumuk, Francisco J Orlandi, Ticiana A Leal, Olivier Molinier, Nopadol Soparattanapaisarn, Adrian Langleben, Raffaele Califano, Balazs Medgyasszay, Te-Chun Hsia, Gregory A Otterson, Lu Xu, Bilal Piperdi, Ayman Samkari, Martin Reck, null null
Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (21) (2021)
David Planchard, Michael J Boyer, Jong-Seok Lee, Arunee Dechaphunkul, Parneet K Cheema, Toshiaki Takahashi, Jhanelle E Gray, Marcello Tiseo, Suresh S Ramalingam, Alexander Todd, Astrid McKeown, Yuri Rukazenkov, Yuichiro Ohe
Postprogression Outcomes for Osimertinib versus Standard-of-Care EGFR-TKI in Patients with Previously Untreated EGFR-mutated Advanced Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (7) (2019)
Damiano Rondelli, Judith D Goldberg, Luis Isola, Leah S Price, Tsiporah B Shore, Michael J Boyer, Andrea Bacigalupo, Alessandro Rambaldi, Marco Scarano, Rebecca B Klisovic, Vikas Gupta, Bjorn Andreasson, John O Mascarenhas, Meir Wetzler, Alessandro M Vannucchi, Josef T Prchal, Vesna Najfeld, Attilio Orazi, Rona S Weinberg, Crystal Miller, Giovanni Barosi, Lewis R Silverman, Giuseppe Prosperini, Roberto Marchioli, Ronald Hoffman
MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis. Blood 124 (7) (2014)

Michael J Boyer.css-eqlu8i{font-size:small;padding-left:4px;} (M Boyer, Michael Boyer)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Boyer (M Boyer, Michael Boyer)